A Brief Measure for Assessing Generalized Anxiety Disorder: The GAD-7
Abstract
BACKGROUND: Generalized anxiety disorder (GAD) is one of the most common mental disorders; however, there is no brief clinical measure for assessing GAD. The objective of this study was to develop a brief self-report scale to identify probable cases of GAD and evaluate its reliability and validity. METHODS: A criterion-standard study was performed in 15 primary care clinics in the United States from November 2004 through June 2005. Of a total of 2740 adult patients completing a study questionnaire, 965 patients had a telephone interview with a mental health professional within 1 week. For criterion and construct validity, GAD self-report scale diagnoses were compared with independent diagnoses made by mental health professionals; functional status measures; disability days; and health care use. RESULTS: A 7-item anxiety scale (GAD-7) had good reliability, as well as criterion, construct, factorial, and procedural validity. A cut point was identified that optimized sensitivity (89%) and specificity (82%). Increasing scores on the scale were strongly associated with multiple domains of functional impairment (all 6 Medical Outcomes Study Short-Form General Health Survey scales and disability days). Although GAD and depression symptoms frequently co-occurred, factor analysis confirmed them as distinct dimensions. Moreover, GAD and depression symptoms had differing but independent effects on functional impairment and disability. There was good agreement between self-report and interviewer-administered versions of the scale. CONCLUSION: The GAD-7 is a valid and efficient tool for screening for GAD and assessing its severity in clinical practice and research.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
TACTICs may significantly reduce moderate-to-severe anxiety in ADRD caregivers.
“Third, preliminary effects suggest that TACTICs may significantly reduce moderate-to-severe anxiety, a common and disruptive symptom among ADRD caregivers [31].”
From Feasibility and acceptability of an acceptance and commitment therapy intervention for caregivers of adults with Alzheimer’s disease and related dementias (2021) · cites this paper as [31]
The non-reactivity subscale of the Five Facet Mindfulness Questionnaire is validated for independent use to assess emotional reactivity.
“The non-reactivity subscale is validated for use independently and is composed of 7 questions from the 39-item FFMQ (30).”
From Targeting Anxiety to Improve Sleep Disturbance: A Randomized Clinical Trial of App-Based Mindfulness Training. (2022) · cites this paper as [30]
The GAD-7 had good internal reliability at trial pre-intervention (ωTotal = 0.90).
“the Generalized Anxiety Disorder-7 scale (GAD-7, ωTotal = 0.90; Spitzer et al., 2006)”
From Examining the effects of prior Acceptance and Commitment Therapy (ACT) treatment among anxious cancer survivors during the COVID-19 pandemic: Evidence from a randomized controlled trial (2022) · cites this paper as Spitzer et al., 2006
The GAD-7 is a validated measure of anxiety symptoms over the past two weeks with internal consistency of .92.
“The Generalized Anxiety Disorder Screener (GAD-7) measures symptoms of anxiety over the past two weeks using 7 items (Cronbach’s α = .92)48.”
The GAD-7 has good reliability (Cronbach's alpha = .92; test-retest intraclass correlation = 0.83) and both criterion and construct validity in a large multisite primary care sample.
“A large, multisite study including 2,740 adult patients in primary care settings demonstrated that this measure has good reliability (Cronbach α = .92 and test-re-test intraclass correlation = 0.83) and both criterion and construct validity”
From Patient-Reported Outcomes Measurement Information System (PROMIS) Instruments: Reliability and Validity in Veterans Following Orthopedic Surgery. (2020) · cites this paper as Spitzer et al., 2006
The results support the literature that demonstrates students' eagerness to be connected with alternative methods of managing mental health concerns.
“Our results support the literature that demonstrates students’ eagerness to be connected with alternative methods of managing mental health concerns.31–33”
From Aligning students and counseling centers on student mental health needs and treatment resources. (2022) · cites this paper as [33]
The GAD-7 has adequate internal consistency and established criterion, construct, and procedural validity.
“Internal consistency was adequate in the validation study, and criterion, construct, and procedural validity were established (Spitzer et al., 2006).”
From Effects of traumatic experiences on obsessive-compulsive and internalizing symptoms: The role of avoidance and mindfulness. (2018) · cites this paper as Spitzer et al., 2006
The GAD-7 is a brief seven-item screening tool for GAD.
“GAD-7.82”
From Acceptance and commitment therapy for older people with treatment-resistant generalised anxiety disorder: The FACTOID feasibility study (2021) · cites this paper as [82]
GAD-7 is a validated, reliable 7-item questionnaire used to screen for general anxiety disorder and measure anxiety symptom severity over the past two weeks.
“The Generalized Anxiety Disorder 7 (GAD-7) is a validated, reliable 7 item questionnaire used to screen for the presence of general anxiety disorder and to measure anxiety symptom severity over the past 2 weeks. 21”
From A Pilot Randomized Controlled Trial to Assess the Impact of Motivational Interviewing on Initiating Behavioral Therapy for Migraine (2020) · cites this paper as [21]
The GAD-7 demonstrated strong psychometric properties in the general population and adequate internal consistency.
“The GAD-7 has shown strong psychometric properties in the general population, including adequate internal consistency, α = 0.89 (0.89 in the current sample)”
From Health, well-being, and persisting symptoms in the pandemic: What is the role of psychological flexibility? (2022) · cites this paper as Spitzer et al., 2006
Average baseline depression, anxiety, and pain catastrophizing scores were well below clinical cut-offs, suggesting some restriction of range in this sample.
“Average baseline depression, anxiety, and pain catastrophizing scores were well below clinical cut-offs indicating elevated symptoms [31–33], suggesting some restriction of range in this sample.”
The primary outcome was anxiety symptom severity assessed at baseline and post using the GAD-7.
“The primary outcome was anxiety symptom severity assessed at baseline and post using the GAD-7 (α =.67-.89; Spitzer et al., 2006).”
From Brief modular anxiety intervention for primary care: Hybrid I pilot randomized controlled trial of feasibility, acceptability, effectiveness, and implementation potential (2024) · cites this paper as Spitzer et al., 2006
Anxiety and depressive symptom severity were assessed using the GAD-7 and PHQ-9.
“Anxiety and depressive symptom severity (last 2 weeks) were assessed using the GAD-7 (Spitzer et al., 2006) and PHQ-9 (Kroenke et al., 2001), respectively.”
From Brief modular anxiety intervention for primary care: Hybrid I pilot randomized controlled trial of feasibility, acceptability, effectiveness, and implementation potential (2024) · cites this paper as Spitzer et al., 2006
The GAD-7 has good reliability and construct criterion validity for clinical populations and has been validated in a Japanese sample.
“Reliability and construct criterion validity have been reported to be good for clinical populations (Spitzer et al., 2006). The GAD-7 was also validated in a Japanese sample (Muramatsu et al., 2009).”
From The conditional process model of mindfulness and emotion regulation: An empirical test (2017) · cites this paper as Spitzer et al., 2006
Validated mental health screeners were administered at baseline for depression, generalized anxiety, panic disorder, post-traumatic stress disorder, social anxiety, and at-risk drinking.
“Validated mental health screeners administered at baseline covered depression [CES-D (Radloff 1977); positive screen is ≥16], generalized anxiety [GAD-7 (Spitzer et al., 2006); positive screen is ≥ 10], panic disorder [ANSQ (Stein et al., 1999)]”
From Smokers with bipolar disorder, other affective disorders, and no mental health conditions: Comparison of baseline characteristics and success at quitting in a large 12-month behavioral intervention randomized trial. (2018) · cites this paper as Spitzer et al., 2006
The GAD-7 is stratified into four levels of symptom severity: minimal, mild, moderate, and severe anxiety.
“The GAD-7 is stratified into four levels of symptom severity: minimal, mild, moderate, and severe anxiety.”
From An examination of psychological distress and moral injury in journalists exposed to online harassment (2025) · cites this paper as Spitzer et al., 2006
The GAD-7 is a widely used efficient screening questionnaire with excellent psychometric properties, including internal consistency (α = .91) and criterion, construct, and factorial and procedural validity.
“The GAD-7 is a widely used efficient screening questionnaire with excellent psychometric properties, including internal consistency (α = .91) and criterion, construct, and factorial and procedural validity.”
From Pathways of association between disordered eating in adolescence and mental health outcomes in young adulthood during the COVID-19 pandemic (2023) · cites this paper as Spitzer et al., 2006
The PHQ-9 demonstrates robust criterion, construct, and external validity.
“The PHQ-9 demonstrates robust criterion, construct, and external validity. 13”
From Mental Health, Suicidality, Health, and Social Indicators Among College Students Across Nine States in India (2025) · cites this paper as [13]
The GAD-7 internal consistency was estimated at 0.92.
“and its internal consistency was estimated at 0.92. 13”
From Mental Health, Suicidality, Health, and Social Indicators Among College Students Across Nine States in India (2025) · cites this paper as [13]
The PHQ-9 is a validated nine-item screening tool aligned with DSM-IV criteria for depressive disorders.
“Symptoms related to depression were assessed using the Patient Health Questionnaire (PHQ-9), a validated nine-item screening tool aligned with criteria for depressive disorders as outlined in the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). 13”
From Mental Health, Suicidality, Health, and Social Indicators Among College Students Across Nine States in India (2025) · cites this paper as [13]
A score of 10 or greater on the Chinese version of GAD-7 represents a reasonable cut point for identifying cases of anxiety.
“A score of 10 or greater represents a reasonable cut point for identifying cases of anxiety[15,16]”
From Mental health problems and social media exposure during COVID-19 outbreak (2020) · cites this paper as [15]
Anxiety was measured with the Generalized Anxiety Disorder measure (GAD-7), with Cronbach's alpha 0.89.
“The Generalized Anxi -ety Disorder measure (GAD-7; Spitzer et al., 2006) asked about the frequency of anxious feelings over the prior two weeks using a 3-point Likert scale ranging from 0 ( not at all ) to 3 ( nearly every day ). Cronbach's alpha was 0.89.”
From Separate and Cumulative Impacts of Trauma-Informed Practices and a Housing Intervention on the Safety, Housing Stability and Mental Health of Domestic Violence Survivors Over Two Years (2025) · cites this paper as Spitzer et al., 2006
The self-reported PHQ-9, GAD-7, SIGH-ADS and Young Mania Rating Scale are validated tools which can effectively track symptom severity and treatment response in clinical and research settings.
“are validated tools which can effectively track symptom severity and treatment response in clinical and research settings.”
From Light therapy for bipolar disorders: Clinical recommendations from the international society for bipolar disorders (ISBD) Chronobiology and Chronotherapy Task Force (2025) · cites this paper as Spitzer et al. 2006
The study used validated psychometric tests: the Generalized Anxiety Disorder-7, the Patient Health Questionnaire-9, and the Peyronie's Disease Questionnaire symptom bother.
“All patients completed the following questionnaires: a visual analog scale (VAS) questionnaire for pain assessment; the International Index of Erectile Function (IIEF) for the evaluation of erectile function; and three validated psychometric tests: the Generalized Anxiety Disorder-7 questionnaire (GAD-7, for the assessment of anxiety), the Patient Health Questionnaire-9 (PHQ-9, for the assessment”
From Clinical Presentation of Peyronie’s Disease: A Retrospective Study of 564 Cases (2024) · cites this paper as [58]
A GAD-7 score ≥ 10 was used to indicate the presence of anxiety symptoms.
“A total GAD score ≥ 10 points was taken to indicate the presence of anxiety symptoms [17].”
From Depression, anxiety, and stress in Korean general population during the COVID-19 pandemic. (2022) · cites this paper as [17]
GAD-7 has good concurrent validity (72% sensitivity for social anxiety disorder), and test-retest reliability (ρ = 0.83).
“GAD-7 has been reported with good concurrent validity (72% sensitivity for social anxiety disorder), and test–retest reliability (ρ = 0.83) [21].”
From Academic Stress, Physical Activity, Sleep, and Mental Health among Chinese Adolescents (2021) · cites this paper as [21]
Internal consistency of the Generalized Anxiety Disorder Seven-Item in the present sample was good (α = 0.89).
“Internal consistency in the present sample was good (α = 0.89).”
From Effectiveness of Acceptance and Commitment Therapy in Increasing Resilience and Reducing Attrition of Injured US Navy Recruits. (2018) · cites this paper as [41]
The Generalised Anxiety Disorder 7-Item measure has been shown to be reliable and valid for a range of anxiety disorders, and its internal consistency in the current study was excellent (α = .90).
“The measure has been shown to be both reliable and valid for a range of anxiety disorders, 37 and internal consistency in the current study was excellent (α = .90).”
From Internet-Delivered Psychological Pain-Management for Young Adults With Chronic Pain: An Investigation of Clinical Trial Data (2024) · cites this paper as [37]
The GAD-7 has excellent internal consistency (Cronbach's alpha = 0.92) and extensive reliability and validity data.
“It consists of 7 items measuring symptoms of anxiety and has extensive reliability and validity data.It has excellent internal consistency (Cronbach's alpha = 0.92) [32].”
From Rates of depression and anxiety in Italian patients with cystic fibrosis and parent caregivers: Implementation of the Mental Health Guidelines (2020) · cites this paper as [32]
The GAD-7 had acceptable internal consistency in the present sample (α = .78).
“In the present sample, internal consistency was acceptable (α = .78).”
The Generalized Anxiety Disorder-7 (GAD-7) has good reliability as well as good criterion and construct validity.
“The measure has good reliability as well as good criterion and construct validity (Spitzer et al ., 2006).”
From Effectiveness and predictors of group cognitive behaviour therapy outcome for generalised anxiety disorder in an out-patient hospital setting (2024) · cites this paper as Spitzer et al., 2006
GAD-7 is a validated questionnaire commonly used to assess generalised anxiety symptoms and their severity.
“GAD-7 is a validated questionnaire commonly used to assess generalised anxiety symptoms and their severity [24, 30].”
GAD-7 measures symptoms of anxiety based on DSM-IV criteria for generalized anxiety disorder.
“GAD-7 measures symptoms of anxiety, based on the generalized anxiety disorder criteria in DSM-IV; APA, 1994).”
From ØCD: protocol for the development and evaluation of a cognitive-behavioral prevention program for obsessive-compulsive disorder (2024) · cites this paper as [29]
Participants scoring ≥10 in either GAD-7 or PHQ-8 were deemed at risk of generalised anxiety disorder or depressive disorder.
“Participants who scored ≥ 10 in either the GAD-7 or PHQ-8 were deemed at risk of generalised anxiety disorder or depressive disorder [22, 23]”
From Young People’s Barriers and Facilitators of Engagement with Web-Based Mental Health Interventions for Anxiety and Depression: A Qualitative Study (2024) · cites this paper as [22]
The GAD-7 has good test-retest reliability and construct validity.
“The GAD-7 has been found to have good test -retest reliability and construct validity.”
From Partner symptom accommodation in generalized anxiety disorder: A preliminary examination of correlates with symptoms and cognitive behavioural therapy outcome (2024) · cites this paper as Spitzer et al., 2006
The GAD-7 has good psychometric properties with good internal consistency in prior work, and Cronbach's alpha in the current study was 0.92.
“The GAD-7 has good psychometric properties with good internal consistency (Cronbach Alpha = 0.89) (Spitzer et al., 2006). The Cronbach's alpha for the current study was 0.92.”
From The role of experiential avoidance and cognitive fusion in the development of anxiety symptoms among family carers of people with dementia (2024) · cites this paper as Spitzer et al., 2006
The General Anxiety Disorder Scale is a 7-item module of the PHQ, with scores of ≥5, ≥10 and ≥15 considered the cut-off for mild, moderate and severe generalised anxiety, respectively.
“The General Anxiety Disorder Scale is a 7-item module of the PHQ, which screens for and assesses the severity of a generalised anxiety disorder on a 4-point Likert scale from 0 (‘not at all’) to 3 (‘nearly every day’).33 Scores of ≥5, ≥10 and ≥15 are considered the cut-off for mild, moderate and severe generalised anxiety, respectively.”
GAD-7 scores at 1-year follow-up represented a shift from moderate anxiety (score 10-14) to mild anxiety (score 5-9) for both groups.
“The scores observed at 1-year follow-up on the GAD-7 represent a shift from a classification of moderate anxiety (score 10-14) to mild anxiety (score of 5-9) for both groups (Spitzer et al., 2006).”
From Exercise combined with Acceptance and Commitment Therapy for chronic pain: One-year follow-up from a randomized controlled trial (2024) · cites this paper as Spitzer et al., 2006
Spitzer R.L. in 2006 and Christensen H. in 2009 have 69 and 66 citations, respectively.
“Publications by Spitzer R.L. in 2006 [45] and Christensen H. in 2009 [46], with 69 and 66 citations, highlight the importance of internet-based mental health interventions.”
The GAD-7 has demonstrated good internal consistency (α=.89) and good test-retest reliability (r=0.83).
“The GAD-7 has demonstrated good internal consistency (α=.89) and good test-retest reliability (r=0.83) [42].”
The GAD-7 has good reliability and validity in its versions in English, Spanish, Brazilian-Portuguese, and Dutch.
“GAD-7 has good reliability and validity in its versions in English (Spitzer et al., 2006), Spanish (Garcia-Campayo et al., 2010), Brazilian-Portuguese (Moreno et al., 2016), and Dutch (Donker et al., 2011).”
From Internet-based self-administered intervention to reduce anxiety and depression symptomatology and improve well-being in 7 countries: protocol of a randomized control trial (2024) · cites this paper as Spitzer et al., 2006
The GAD-7 has demonstrated good reliability and validity.
“The GAD-7 has demonstrated good reliability and validity [42].”
From Feasibility of Guided Internet-Based Cognitive Behavioral Therapy for Panic Disorder and Social Anxiety Disorder in Japan: Pilot Single-Arm Trial (2024) · cites this paper as [42]
The GAD-7 has good reliability and validity.
“The GAD-7 has good reliability and validity”
From Treatment histories, barriers, and preferences for individuals with symptoms of generalized anxiety disorder (2024) · cites this paper as Spitzer et al., 2006
Depression and four prevalent anxiety disorders were screened using well-established and validated self-report measures.
“To screen for depression and four prevalent anxiety disorders, we included well-established and validated self-report measures.”
From Can an Acceptance and Commitment Therapy-Based Smartphone App Help Individuals with Mental Health Disorders Quit Smoking? (2024) · cites this paper as [59]
Anxiety and depression (mood) are frequently reported symptoms in pediatric concussion.
“Anxiety and depression (mood) are frequently reported symptoms in pediatric concussion [73-75].”
The GAD-7 is a psychometrically sound seven-item self-report scale for assessing symptoms of anxiety.
“The Generalized Anxiety Disorder-7 (GAD-7) scale is a psychometrically sound seven-item self-report scale used to assess symptoms of anxiety. 49,50”
From Virtual psychoeducation for improvement of pain catastrophizing in pediatric presurgical patients and caregivers: a proof-of-concept study (2023) · cites this paper as [50]
The GAD-7 is a validated self-report scale that measures anxiety presence and severity.
“The GAD-7 [34] is a validated self-report scale that measures anxiety presence and severity [67].”
From A Virtual Reality-Assisted Cognitive Behavioral Therapy for and With Inuit in Québec: Protocol for a Proof-of-Concept Randomized Controlled Trial (2023) · cites this paper as [34]
GAD-7 scores have been categorized into mild, moderate, and severe anxiety, with cutoffs of 5, 10, and 15.
“The GAD-7 scores have been categorized into mild, moderate, and severe anxiety, with cutoffs of 5, 10, and 15 [34,68].”
From A Virtual Reality-Assisted Cognitive Behavioral Therapy for and With Inuit in Québec: Protocol for a Proof-of-Concept Randomized Controlled Trial (2023) · cites this paper as [34]
The GAD-7 has excellent internal consistency (Cronbach's α = 0.92) and good test-retest reliability (IntraClass Correlation = 0.83).
“Its internal consistency is excellent (Cronbach's α = 0.92), and it has good test-retest reliability (IntraClass Correlation = 0.83; Spitzer et al., 2006).”
From A study protocol of a randomized controlled study of internet-based cognitive behavioral therapy for adult attention deficit hyperactivity disorder (2023) · cites this paper as Spitzer et al., 2006
The Generalized Anxiety Disorder Scale (GAD-7) had good internal consistency reliability (α = 0.83), test-retest reliability (r = 0.83), and criterion, construct factorial, and procedural validity.
“GAD-7 had good internal consistency reliability (α = 0.83), test-retest reliability (r = 0.83), and criterion, construct factorial, and procedural validity (Spitzer et al., 2006).”
From Learning how to recover from stress: Results from an internet-based randomized controlled pilot trial (2023) · cites this paper as Spitzer et al., 2006
GAD-7 is a well-established self-assessment form that measures symptoms of worry.
“GAD-7 is a well-established self-assessment form that measures symptoms of worry (Spitzer et al., 2006).”
From Effectiveness of and processes related to internet-delivered acceptance and commitment therapy for adolescents with anxiety disorders: a randomized controlled trial (2023) · cites this paper as Spitzer et al., 2006
The GAD-7 is a 7-item self-administered questionnaire that serves as a brief clinical measure for assessing the severity of GAD.
“The GAD-7 is a 7-item self-administered questionnaire that serves as a brief clinical measure for assessing the severity of GAD [40].”
Two trials reported adjusted mean differences for anxiety measured using GAD-7, showing no evidence of a difference between groups at over three months and up to six months (MD -0.31, 95% CI -1.90 to 1.28) or at over six months and up to 12 months (MD 0.30, 95% CI -0.40 to 1.00; low-certainty evidence).
“These results showed that there was no evidence of a difference between groups either at over three months and up to six months (MD -0.31, 95% CI -1.90 to 1.28) (Hind 2017) or at over six months and up to 12 months (MD 0.30, 95% CI -0.40 to 1.00; low-certainty evidence; Analysis 1.10) (Wildman 2022).”
From Psychological interventions for improving adherence to inhaled therapies in people with cystic fibrosis (2023) · cites this paper as Spitzer 2006
All the measures employed have excellent or good internal consistency and test-retest reliability and are widely used as outcome measures in chronic pain services.
“All the measures employed have excellent or good internal consistency and test-retest reliability 9,10,14 -16 and are widely used as outcome measures in chronic pain services.”
Previous research proposed reliable change values of 4 and 9 for the GAD-7 and PHQ-9 questionnaires and test-retest reliability values of 0.83 and 0.84, respectively; these were used for the GAD-7 and PHQ-9 analyses.
“Previous research had proposed reliable change values of 4 and 9 for the GAD-7 and PHQ-9 questionnaires 19 and testretest reliability values of 0.83. 9 and 0.84, 10 respectively. These were used for GAD-7 and PHQ-9 analyses.”
The PHQ-ADS is a validated measure of the combined sum score of the PHQ-9 and GAD-7.
“The PHQ-ADS is a validated measure of the combined sum score of the Patient Health Questionnaire depression module (PHQ-9) [55] and Generalized Anxiety Disorder (GAD-7) [56] questionnaire (see secondary outcomes).”
The GAD-7 is sensitive to DSM-IV-congruent GAD, social phobia, and panic disorder, and has good psychometric properties.
“The GAD-7 is sensitive to DSM-IV-congruent GAD, social phobia, and panic disorder, and has good psychometric properties (Spitzer et al., 2006).”
From An open trial of the feasibility of brief internet-delivered acceptance and commitment therapy (iACT) for chronic anxiety and depression (2023) · cites this paper as Spitzer et al., 2006
Emotional distress was assessed with the well-validated 7-item Generalized Anxiety Disorder questionnaire (GAD-7).
“We assessed emotional distress with the well-validated 7-item Generalized Anxiety Disorder questionnaire (GAD-7) [31,32] and the 8-item Patient Health Questionnaire (PHQ-8) [33,34].”
From Pilot randomized trial of an acceptance-based telehealth intervention for women with ovarian cancer and PARP inhibitor-related fatigue (2023) · cites this paper as [31]
The GAD-7 has excellent reliability and internal consistency (Cronbach α=.89).
“The GAD-7 has excellent reliability and internal consistency (Cronbach α=.89 [48,49]).”
From Feasibility and Preliminary Efficacy of Digital Interventions for Depressive Symptoms in Working Adults: Multiarm Randomized Controlled Trial (2023) · cites this paper as [48]
Participants were not depressed (<10) or mildly anxious (<5) on average.
“Threshold scores for depression, anxiety and diabetes distress indicated that participants were not depressed (<10) (Kroenke et al., 2009) or mildly anxious (<5) (Spitzer et al., 2006) on average.”
From An online acceptance, commitment, and self-compassion based treatment to decrease psychological distress in people with type 2 diabetes: A feasibility randomised-controlled trial (2023) · cites this paper as Spitzer et al., 2006
The GAD-7 is a questionnaire with good validity and reliability.
“we used the Generalized Anxiety Disorder scale (GAD-7), which is a questionnaire with good validity and reliability [41].”
From Changes of Symptoms of Anxiety, Depression, and Fatigue in Cancer Patients 3 Months after a Video-Based Intervention (2023) · cites this paper as [41]
By integrating the GAD-7 and PHQ-9 into the platform, recommendations and referrals will be clinically valid in terms of criterion, construct, factorial, and procedural validity.
“By integrating the standardized measures of the Generalized Anxiety Disorder 7-item scale (GAD-7) and the Patient Health Questionnaire 9-item scale (PHQ-9) into the platform, recommendations and referrals will be clinically valid in terms of criterion, construct, factorial, and procedural validity (see [31,32] for GAD-7 validity testing and [33,34] for PHQ-9 validity testing).”
From Providing Self-Led Mental Health Support Through an Artificial Intelligence–Powered Chat Bot (Leora) to Meet the Demand of Mental Health Care (2023) · cites this paper as [31]
Our findings indicate that SWiM-C reduced experiential avoidance and increased psychological flexibility.
“Accordingly, our findings indicate that SWiM-C reduced experiential avoidance (i.e., attempts to control/avoid unwanted internal experiences such as negative emotions, thoughts, or cravings due to unwillingness to experience them [16, 27]) and increased psychological flexibility (i.e., the ability to act in accordance with personal values despite the presence of interfering emotions, thoughts, and”
From Supporting Weight Management during COVID-19: A Randomized Controlled Trial of a Web-Based, ACT-Based, Guided Self-Help Intervention (2022) · cites this paper as [16]
ACT-based interventions are the most effective behavioural treatment for long-term weight change among third-wave cognitive behaviour therapies and may improve mental wellbeing and psychological determinants of weight control.
“Evidence shows that interventions based on ACT [16] are the most effective behavioural treatment for long-term weight change among third-wave cognitive behaviour therapies and may improve mental wellbeing and psychological determinants of weight control [17].”
From Supporting Weight Management during COVID-19: A Randomized Controlled Trial of a Web-Based, ACT-Based, Guided Self-Help Intervention (2022) · cites this paper as [16]
The GAD-7 has good reliability and validity.
“The GAD-7 had good reliability and validity (Spitzer et al., 2006).”
From Feasibility of guided internet-based cognitive behavioral therapy for patients with anorexia nervosa (2022) · cites this paper as Spitzer et al., 2006
The GAD-7 is a widely used seven-item anxiety screener with well-established psychometric qualities.
“Anxiety symptom severity was measured with the GAD-7, a widely used seven-item anxiety screener with well-established psychometric qualities (total scores 0–21, higher scores indicating greater symptom severity) [24].”
All outcome measures used in the study have been statistically validated and have demonstrated good internal consistency in prior trials.
“All measures have been statistically validated and have demonstrated good internal consistency in prior trials [31, 42].”
From Feasibility and acceptability of an acceptance and commitment therapy intervention for caregivers of adults with Alzheimer’s disease and related dementias (2021) · cites this paper as [31]
The GAD-7 is a well-established self-assessment scale that measures symptoms of worry/anxiety.
“(Generalized Anxiety Disorder 7-item scale; Spitzer et al., 2006) is a well-established self-assessment scale that measures symptoms of worry/anxiety.”
From Effects of patient-driven iCBT for anxiety in routine primary care and the relation between increased experience of empowerment and outcome: A randomized controlled trial (2021) · cites this paper as Spitzer et al., 2006
The Generalized Anxiety Disorder Questionnaire-7 item has demonstrated good psychometric properties in previous samples.
“The scale has demonstrated good psychometric properties in previous samples [21, 24, 46].”
From Internet videoconferencing delivered cognitive behavior therapy for generalized anxiety disorder: protocol for a randomized controlled trial (2022) · cites this paper as [46]
A Generalized Anxiety Disorder Questionnaire-7 item score of 10 or above indicates clinically significant symptoms of generalized anxiety disorder.
“A score of 10 or above indicates clinically significant symptoms of generalized anxiety disorder [46].”
From Internet videoconferencing delivered cognitive behavior therapy for generalized anxiety disorder: protocol for a randomized controlled trial (2022) · cites this paper as [46]
GAD-7 measures symptoms of anxiety with excellent internal consistency (α=0.92) and 0.83 intraclass correlation.
“The Generalized Anxiety Disorder Assessment -7 (GAD-7) (Spitzer et al., 2006) measures symptoms of anxiety with an excellent internal consis tency ( α = 0.92) and 0.83 in intraclass correlation.”
From Acceptance and Commitment Therapy for inpatients with psychosis –an acceptability and feasibility single case AB designed study (2022) · cites this paper as Spitzer et al., 2006
The GAD-7 has been validated in adult populations, with a Cronbach ɑ of .92 and high convergent and discriminant validity.
“The GAD-7 has been validated in adult populations, with a Cronbach ɑ of .92 and high convergent and discriminant validity [32].”
From A Cognitive Behavioral Therapy Chatbot (Otis) for Health Anxiety Management: Mixed Methods Pilot Study (2022) · cites this paper as [32]
The GAD-7 has excellent reliability and internal consistency (Cronbach α of .89 in the original validation and .91 in this study at t0) and has been validated in both the general population and primary care settings.
“The GAD-7 has excellent reliability and internal consistency (Cronbach α of .89 in the original validation and .91 in this study at t0) and has been validated in both the general population and primary care settings [45,46].”
The sample size was calculated as n = 62 per trial group, adjusted for cluster effects and 15% dropout to aim for n = 162 (n = 81 per group).
“A sample size of n = 62 per trial group was calculated with NQuery Advanced version 8.1 (Statistical Solutions) using a 2-sided χ2 test with power at 80% and significance level at 5%. A cluster size of 5 patients per physician, estimated intracluster correlation coefficient of 2.5%, corrected by 10% for cluster effects, resulted in a sample size of n = 69 per group. Adjusting for 15% dropout, we a”
The PHQ-9 and GAD-7 are well-validated measures of depression and anxiety, respectively.
“Assessments consisted of the PHQ-9 [31] and the GAD-7 [32], well-validated measures of depression and anxiety, respectively.”
From Blended care-cognitive behavioral therapy for depression and anxiety in real-world settings: Pragmatic retrospective study (2020) · cites this paper as [32]
Anxiety and depression were measured using the 7-item Generalized Anxiety Disorder Assessment (GAD-7) and the 9-item Patient Health Questionnaire (PHQ-9), respectively, over the previous 2 weeks.
“The 7-item Generalized Anxiety Disorder Assessment (GAD-7) [66] and the 9-item Patient Health Questionnaire (PHQ-9) [67] are clinical assessment tools for measuring anxiety and depression, respectively, over the previous 2 weeks.”
From Development and feasibility of a digital acceptance and commitment therapy⇓based intervention for generalized anxiety disorder: Pilot acceptability study (2021) · cites this paper as [66]
The GAD-7 has very good internal consistency (Cronbach's α = 0.92).
“Internal consistency is very good with Cronbach's α = 0.92 (Spitzer et al., 2006).”
The GAD-7 cut-off of 10 identifies generalised anxiety disorder with good sensitivity (0.89) and specificity (0.82).
“Scores range from 0 to 21 with a cut-off of 10 identifying the generalised anxiety disorder with good sensitivity (0.89) and specificity (0.82).”
From Factors impacting resilience as a result of exposure to COVID-19: The ecological resilience model (2021) · cites this paper as [33]
The GAD-7 has good psychometric properties with good internal consistency (Cronbach's alpha = .92).
“The GAD-7 has good psychometric properties with good internal consistency (Cronbach's alpha = .92) (Spitzer et al., 2006).”
From Exploring the impact of carer stressors and psychological inflexibility on depression and anxiety in family carers of people with dementia (2020) · cites this paper as Spitzer et al., 2006
The GAD-7 is a valid and reliable instrument to screen for generalised anxiety disorder.
“Overall, the GAD-7 is a valid and reliable instrument to screen for generalised anxiety disorder.74 75”
At a cutoff score of 9, the GAD-7 yielded a sensitivity of 89% and a specificity of 82% for detecting anxiety compared with a structured psychiatric interview.
“At a cutoff score of 9 based on the GAD-7 yielded a sensitivity of 89% and a specificity of 82% for detecting anxiety compared with a structured psychiatric interview [18].”
The GAD-7 scale is a self-reported, 7-item questionnaire that allows for rapid detection of generalized anxiety disorder.
“General Anxiety Disorder-7 (GAD-7) scale consists of a self-reported, 7-item questionnaire that allows for the rapid detection of generalized anxiety disorder [18].”
The GAD-7 is a widely accepted anxiety scale that evaluates scores as either mild, moderate, or severe anxiety.
“the GAD-7 scale (a widely accepted anxiety scale that evaluates scores as either mild, moderate, or severe anxiety)”
From Technology enabled clinical care (TECC): Protocol for a prospective longitudinal cohort study of smartphone-augmented mental health treatment (2021) · cites this paper as [47]
The PHQ-9 measures depression rates from minimal depression to severe depression.
“the PHQ-9 (which measures depression rates from minimal depression to severe depression)”
From Technology enabled clinical care (TECC): Protocol for a prospective longitudinal cohort study of smartphone-augmented mental health treatment (2021) · cites this paper as [47]
The GAD-7 is widely used for assessing anxiety severity and is well validated in its German version.
“Anxiety severity during the past two weeks will be assessed with the 7-item Generalized Anxiety Disorder Scale (GAD-7; Spitzer et al., 2006), which is widely used for this purpose and well validated in its German version (Löwe et al., 2008).”
From The efficacy of automated feedback after internet-based depression screening: Study protocol of the German, three-armed, randomised controlled trial DISCOVER (2021) · cites this paper as Spitzer et al., 2006
A number of tools have been utilised and validated to screen depression (PHQ-9, HADS) and anxiety (HADS, GAD-7) in diabetes.
“a number of tools have been utilised and validated to screen depression (PHQ-9 [50, 51], HADS [52, 53]) and anxiety (HADS [52], Generalised Anxiety Disorder 7-item scale (GAD-7) [54, 55]) in diabetes.”
The Generalised Anxiety Disorder scale (GAD-7) has demonstrated good reliability (internal and test-retest) and construct validity, with strong associations with other established measures of anxiety and diagnoses of GAD.
“The GAD-7 has demonstrated good reliability (internal and test - re-test) and construct validity, with strong associations with other established measures of anxiety as well as diagnoses of GAD(Kroenke et al., 2007; L € owe et al., 2008; Spitzer et al., 2006)”
From Acceptability and Co-Development of an Online Cognitive Bias Modification Intervention for Emerging Adults With Hazardous Alcohol Use and Social Anxiety: A Mixed Methods Study (2020) · cites this paper as Spitzer et al., 2006
The GAD-7 is a reliable and valid 7-item measure of generalised anxiety symptoms over the previous two weeks.
“Anxiety symptoms were measured using the General Anxiety Disorder-7 item (GAD-7) [30], a reliable and valid 7-item measure of generalised anxiety symptoms over the previous two weeks [31].”
From A pilot evaluation of a smartphone application for workplace depression (2020) · cites this paper as [30]
The self-report measures described in the study are well-established.
“given that the self-report measures described below are well-established”
From ACT with CF: A telehealth and in-person feasibility study to address anxiety and depressive symptoms among people with cystic fibrosis (2021) · cites this paper as [19]
The GAD-7 is a 7-item self-report scale assessing anxiety symptoms over the past 2 weeks, with total scores categorized as none (0-4), mild (5-9), moderate (10-14), and severe (≥15).
“The 7-item Generalized Anxiety Disorder scale (GAD-7) [34] is a 7-item self-report scale based on a 4-point Likert scale, ranging from 0 (not at all) to 3 (nearly every day).”
The GAD-7 has excellent internal consistency, good test-retest reliability, and strong criterion and construct validity.
“The scale has an excellent internal consistency, good testretest reliability and strong criterion and construct validity (Spitzer et al., 2006).”
From Internet-delivered acceptance and commitment therapy as microlearning for chronic pain: A randomized controlled trial with 1-year follow-up (2021) · cites this paper as Spitzer et al., 2006
The GAD-7 is a seven-item scale that assesses symptoms of generalised anxiety disorder in the last two weeks, and it has demonstrated reliability and validity.
“Total scores on the seven-item scale range from 0 to 21 (higher scores indicating greater severity) based on patient ratings of their symptoms of generalised anxiety disorder (GAD) in the last two weeks. The measure has demonstrated reliability and validity [18].”
From Testing the psychometric properties of the illness perceptions questionnaire for OCD (IPQ-O) (2019) · cites this paper as [18]
The GAD-7 is reliable and valid in the typically developing population.
“The scale has been found to be reliable and valid in the typically developing population 56 (Cronbach ' s α = 0.92).”
From Guided self-help for depression in autistic adults: The ADEPT feasibility RCT (2019) · cites this paper as [56]
The General Anxiety Disorder-7 (GAD-7) is a validated and standardised measure of anxiety.
“The General Anxiety Disorder 7 (GAD-7) a validated and standardised measure, will be used to measure anxiety.64”
From Investigating the effectiveness of an online acceptance and commitment therapy (ACT) intervention versus a waiting list control condition on pain interference and quality of life in adults with chronic pain and multimorbidity: Protocol for a randomised controlled trial (2019) · cites this paper as [64]
The PHQ-9 is validated and reliability in the current study was .95.
“Depressive symptomatology was assessed using the Patient Health Questionnaire for Depression (PHQ-9; Spitzer et al., 2006, Spitzer et al., 1999), which is a widely-used self-report measure that has been validated in different populations (Gräfe et al., 2004, Hinz et al., 2016).”
From The relationship between acceptance, fatigue, and subjective cognitive impairment in hematologic cancer survivors (2019) · cites this paper as Spitzer et al., 2006
The GAD-7 is validated in German and reliability in the present study was .89.
“We assessed anxious symptoms using the Generalized Anxiety Disorder Screener (GAD-7; Spitzer et al., 2006). The one-dimensional scale has been validated in German and shows good psychometric properties (Löwe et al., 2008, Spitzer et al., 2006).”
From The relationship between acceptance, fatigue, and subjective cognitive impairment in hematologic cancer survivors (2019) · cites this paper as Spitzer et al., 2006
A GAD-7 total score of 10 or more indicates a probable GAD diagnosis, with sensitivity of 89% and specificity of 82%.
“A total score of 2265 10 indicates a probable GAD diagnosis (sensitivity = 89% and specificity = 82%; Spitzer et al., 2006).”
From The Mediating Relationship between Maladaptive Behaviours, Cognitive Factors, and Generalised Anxiety Disorder Symptoms (2018) · cites this paper as Spitzer et al., 2006
The Generalised Anxiety Disorder 7-item scale has good sensitivity (89%) and specificity (82%) for GAD scores >10.
“The GAD-7 has good sensitivity (89%) and specificity (82%) for GAD scores >10.34”
From Pilot evaluation of the Sleep Ninja: A smartphone application for adolescent insomnia symptoms (2019) · cites this paper as [34]
The GAD-7 is a reliable 7-item self-report questionnaire for measuring symptoms of anxiety during the last 2 weeks.
“The GAD-7 is a reliable 7-item self-report questionnaire that measures symptoms of anxiety during the last 2 weeks (40).”
The GAD-7 has good reliability and validity.
“The 7-item anxiety scale has good reliability and validity [28].”
From CareACT - internet-based intervention for enhancing the psychological well-being of elderly caregivers - a study protocol of a controlled trial (2019) · cites this paper as [28]
The GAD-7 is a 7-item validated self-report questionnaire used to identify probable cases of GAD and screening for the diagnosis of GAD according to DSM-IV criteria.
“The GAD-7 is a 7-item validated self-report questionnaire used to identify probable cases of GAD and screening for the diagnosis of GAD according to Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) criteria.39”
Two small-scale RCTs by Lundgren et al. showed significant improvements in quality of life following a short-term ACT treatment.
“two small-scale RCTs by Lundgren et al. showed significant improvements in quality of life following a short-term ACT treatment [43, 44]”
From A prospective service evaluation of acceptance and commitment therapy for patients with refractory epilepsy (2015) · cites this paper as [43]
The finding of improvement in quality of life and work and social adjustment is concordant with existing evidence from controlled studies of CBT and ACT for epilepsy.
“This finding is concordant with existing evidence from a small number of controlled studies of cognitive behavioural therapy and ACT for epilepsy.”
From A prospective service evaluation of acceptance and commitment therapy for patients with refractory epilepsy (2015) · cites this paper as [43]
This finding is in contrast with the findings of the studies by Lundgren et al. who reported a significant decrease in seizure frequency as a result of ACT psychotherapeutic treatment.
“This finding is in contrast with the findings of the studies by Lundgren et al. [43, 44] who reported a significant decrease in seizure frequency as a result of ACT psychotherapeutic treatment.”
From A prospective service evaluation of acceptance and commitment therapy for patients with refractory epilepsy (2015) · cites this paper as [43]
The GAD-7 has good reliability and construct validity with adolescent populations.
“The GAD-7 has good reliability and construct validity with adolescent populations [37].”
From A Virtual Reality–Based Cognitive Defusion Application for Youth Depression and Anxiety: Mixed Methods Experimental Study. (2025) · cites this paper as [37]
The GAD-7 is a 7-item self-report scale initially designed to identify probable cases of Generalized Anxiety Disorder.
“Generalized Anxiety Disorder – 7 (GAD-7; [86, 87]). The GAD-7 is a 7 item self-report scale initially designed to identify probable cases of Generalized Anxiety Disorder (GAD).”
From Acceptance and commitment therapy as a transdiagnostic approach to adolescents with different anxiety disorders: study protocol. (2025) · cites this paper as [86]
In its original version, the GAD-7 presented a Cronbach's alpha of 0.92 and evidence for construct validity in relation to measures of anxiety, depression, and health-related quality of life.
“In its original version [86], the GAD-7 presented a Cronbach’s alpha of 0.92 and evidence for its construct validity was found in relation to measures of anxiety, depression, and health-related quality of life.”
From Acceptance and commitment therapy as a transdiagnostic approach to adolescents with different anxiety disorders: study protocol. (2025) · cites this paper as [86]
Interview participants were purposively sampled based on scores from three validated measures assessing anxiety and quality of life: the GAD-7, the PedsQL Family Impact Module, and the Brief Resilience Scale.
“Interview participants were purposively sampled based on their scores from three validated measures assessing anxiety and quality of life, namely: The Generalized Anxiety Disorder‐7 (GAD‐7) Scale (Spitzer et al., 2006) which is a seven‐item measure that assesses the frequency with which the responder has experienced symptoms of anxiety over the past 2 weeks”
From "I don't grieve as much as I used to": A qualitative study on parents of children with rare and undiagnosed conditions navigating grief in the context of uncertainty. (2025) · cites this paper as Spitzer et al., 2006
Anxiety symptoms were assessed using the validated Chinese version of the Generalized Anxiety Disorder 7-item scale (GAD-7).
“Anxiety symptoms were assessed by adopting the validated Chinese version of the Generalized Anxiety Disorder 7-item scale (GAD-7) [50, 51].”
Anxiety measured by the 7-item Generalized Anxiety Disorder (GAD-7) questionnaire had Cronbach's alpha values of 0.87 at T0, 0.91 at T1, 0.89 at T2, and 0.91 at T3.
“Symptoms of anxiety were evaluated using the 7-item Generalized Anxiety Disorder (GAD-7; Spitzer et al., 2006) questionnaire. The total score was calculated and items were responded to on a scale of 0 (not at all) to 3 (nearly every day). Cronbach’s alpha values were: T0: 0.87; T1: 0.91; T2: 0.89; and T3: 0.91.”
From Pathways to mental well-being for graduates of mindfulness-based cognitive therapy (MBCT) and mindfulness-based stress reduction (MBSR): A mediation analysis of an RCT. (2024) · cites this paper as Spitzer et al., 2006
The GAD-7 is a 7-item self-reported questionnaire for screening and severity measuring of generalized anxiety disorder.
“The GAD-7 (Spitzer et al. 2006) is a 7-item self-reported questionnaire for screening and severity measuring of generalized anxiety disorder.”
From Towards a Treatment for Intolerance of Uncertainty for Autistic Adults: A Single Case Experimental Design Study. (2018) · cites this paper as Spitzer et al. 2006
Both GAD-7 and PHQ-8 exhibit satisfactory construct and criterion validity.
“Both scales exhibit satisfactory construct and criterion validity (Kroenke et al., 2009; Spitzer et al., 2006).”
From A single session online training reduces intolerance of uncertainty and improves mental health in emerging adults. (2025) · cites this paper as Spitzer et al., 2006
The Generalized Anxiety Disorder-7 measure had good validity (sensitivity 89%, specificity 82%), internal reliability (Cronbach's α = .92), and test-retest reliability (ICC = .83) in a primary care sample.
“It had good validity (sensitivity of 89% and specificity of 82%), internal reliability (Cronbach's a of .92),and test-retest reliability (intraclass correlation; ICC = .83)in a primary care sample.”
From Brief group‐based acceptance and commitment therapy for stroke survivors. (2019) · cites this paper as Spitzer et al., 2006
The measures used (EDE-Q v6, PHQ-9, GAD-7) were well-validated.
“Patients completed the following well-validated measures at baseline (Session 1) and at end of therapy (Session 10).”
From Brief group cognitive‐behavioral therapy for bulimia nervosa and binge‐eating disorder: A pilot study of feasibility and acceptability. (2023) · cites this paper as Spitzer et al., 2006
Anxiety alone was measured in 10 studies, for example, the Generalised Anxiety Disorder Assessment in five studies and the Beck Anxiety Inventory in two.
“Anxiety alone was measured in 10 studies, for example, the Generalised Anxiety Disorder Assessment 131 in five studies and the Beck Anxiety Inventory 132 in two.”
From A scoping review to identify process and outcome measures used in acceptance and commitment therapy research, with adults with acquired neurological conditions. (2023) · cites this paper as [131]
The GAD-7 has good psychometric properties, and its validity among older population has also been established.
“The scale has good psychometric properties (Spitzer et al., 2006), and its validity among older population has also been established (Wild et al., 2014).”
From Supported Web-Based Acceptance and Commitment Therapy for Older Family Caregivers (CareACT) Compared to Usual Care. (2022) · cites this paper as Spitzer et al., 2006
The GAD-7 was used to assess anxiety symptoms over the past 2 weeks in nurses.
“The Generalized Anxiety Disorder 7-item scale was used to assess anxiety symptoms over the past 2 weeks in nurses [39].”
Patient-reported outcomes of anxiety, depression, and health-related quality of life were assessed at baseline and post intervention using validated measures (GAD-7, PHQ-9, LupusQoL).
“Patient‐reported outcomes (PROs) were assessed at baseline and post intervention using validated measures for anxiety (General Anxiety Disorder‐7 [GAD‐7]) (13), depression (Patient Health Questionnaire [PHQ‐9]) (14), and health‐related QoL domains (LupusQoL) (15).”
Cronbach's alphas for the GAD-7 were 0.90, 0.91, 0.92 for times 1, 2 and 3, respectively.
“Cronbach ' s alphas were 0.90, 0.91, 0.92 for times 1, 2 and 3, respectively (Spitzer et al., 2006).”
From Cognitive and behavioural factors contributing to distress in LGBTQ+students: a prospective mediation study. (2022) · cites this paper as Spitzer et al., 2006
Among primary care patients, the GAD-7 has an α = 0.82, test-retest reliability intraclass correlation (ICC) of 0.83, strong sensitivity and specificity, with increasing scores strongly associated with multiple domains of functional impairment.
“Among primary care patients, the GAD-7 has an α = 0.82, test-retest reliability intraclass correlation (ICC) of 0.83, strong sensitivity and specificity, with increasing scores strongly associated with multiple domains of functional impairment [58].”
The Seven-Item Generalized Anxiety Disorder Scale (GAD-7) has strong internal consistency (α = 0.92) and is validated for chronic pain patients with migraine.
“The GAD-7 has shown strong internal consistency (Cronbach’s α = 0.92) [57] and is validated for chronic pain patients with migraine [58].”
From ACTsmart: Guided Smartphone-Delivered Acceptance and Commitment Therapy for Chronic Pain—A Pilot Trial. (2021) · cites this paper as [57]
The GAD-7 demonstrated good internal consistency (Cronbach's α = 0.87).
“Anxiety symptoms were measured using the Generalized Anxiety Disorder-7 (GAD-7) [28], which also demonstrated good internal consistency (Cronbach’s α = 0.87).”
From The effect of a therapeutic smartphone application on suicidal ideation in young adults: Findings from a randomized controlled trial in Australia. (2022) · cites this paper as [28]
Anxiety was assessed using four well-established measures as primary outcome measures.
“four well-established measures were used as primary outcome measures”
From Self-guided mindfulness and cognitive behavioural practices reduce anxiety in autistic adults: A pilot 8-month waitlist-controlled trial of widely available online tools. (2020) · cites this paper as Spitzer et al., 2006
The PHQ-9 and GAD-7 are validated and commonly used to identify and measure symptoms of depression and anxiety in patients with chronic illness.
“Both questionnaires are validated and commonly used to identify and measure symptoms of depression and anxiety in patients with chronic illness.”
The GAD-7 is a validated 7-item questionnaire developed as a screener for generalized anxiety disorder.
“The GAD-7 is a validated 7-item questionnaire developed as a screener for generalized anxiety disorder, 20”
From A complementary and integrative health group-based program pilot demonstrates positive health outcomes with female Veterans. (2020) · cites this paper as [20]
The GAD-7 uses well-established cut-off points for mild, moderate, and severe anxiety symptoms.
“This questionnaire uses well-established cut-off points for mild, moderate, and severe anxiety symptoms [48].”
The GAD-7 may also be used as a screener for panic disorder, social anxiety, and post-traumatic stress disorder.
“the scale may also be used as a screener for panic disorder, social anxiety, and post-traumatic stress disorder [48, 55, 62]”
The psychometric properties of the GAD-7 are adequate.
“Psychometric properties of the GAD-7 are adequate”
Angelina reported moderate to severe levels of anxiety and depression on the GAD-7 and PHQ-9, respectively.
“Angelina reported moderate to severe levels of anxiety and depression on the GAD-7 and PHQ-9, respectively”
From Brief Transdiagnostic Intervention for Parents With Emotional Disorder Symptoms During the COVID-19 Pandemic: A Case Example (2021) · cites this paper as Spitzer et al., 2006
Brief versions of outcome measures assessing distress and well-being have been developed and validated.
“researchers have developed and validated brief ver sions of outcome measures assessing distress (e.g., the Patient Health Questionnaire-9 or PHQ-9 for assessing depressive symptoms; Kroenke et al., 2001; the Generalized Anxiety Disorder-7 or GAD-7 for assessing anxiety symptoms; Spitzer et al., 2006) as well as well-being (e.g., the 7item Peace of Mind scale or PoM; Lee et al., 2013).”
From Examining domains of psychological flexibility and inflexibility as treatment mechanisms in acceptance and commitment therapy: A comprehensive systematic and meta-analytic review (2024) · cites this paper as Spitzer et al., 2006
All classes sustained their improvement related to anxiety and depression post-discharge from the hospital, with post-discharge anxiety and depression scores in the normal range.
“All classes sustained their improvement related to anxiety and depression post-discharge from the hospital (i.e., anxiety and depression scores post-discharge were in the normal range”
From Time in treatment: Examining mental illness trajectories across inpatient psychiatric treatment (2020) · cites this paper as Spitzer et al., 2006
Six women showed reliable and clinically significant improvements in childbirth fear (FOBS) and anxiety (GAD-7); two women showed a reliable increase in value-driven behaviour (VLQ), clinically significant for one.
“Overall, there were reliable and clinical improvements for six women regarding their levels of childbirth fear (FOBS; Haines et al., Citation2011) and anxiety (GAD-7; Spitzer et al., Citation2006). Along with two women having a reliable increase in their value driven behaviour (VLQ; Wilson & Groom, Citation2002). This was clinically significant for one of them.”
From The feasibility and acceptability of a single-session Acceptance and Commitment Therapy (ACT) intervention to support women self-reporting fear of childbirth in a first pregnancy. (2023) · cites this paper as Spitzer et al., 2006
The GAD-7 was chosen because it relates to the GAD-2, which is recommended by NICE for routine antenatal care.
“The GAD-7 (Spitzer et al., Citation2006) was chosen as it relates to the GAD-2 (Kroenke et al., Citation2007) which is recommended by NICE (2014) for use routine antenatal care and is a reduction of the GAD-7.”
From The feasibility and acceptability of a single-session Acceptance and Commitment Therapy (ACT) intervention to support women self-reporting fear of childbirth in a first pregnancy. (2023) · cites this paper as Spitzer et al., 2006
The GAD-7 has established reliability, validity, and sensitivity to change.
“the Generalised anxiety Disorder-7 (GaD-7) was used to quantify anxiety symptom severity, with established reliability, validity, and sensitivity to change (spitzer et al. 2006).”
From Feasibility, tolerability, and preliminary effectiveness of an accelerated bilateral intermittent theta-burst stimulation protocol in adults with posttraumatic stress disorder and comorbid depressive disorder following mild traumatic brain injury (2026) · cites this paper as Spitzer et al. 2006
The GAD-7 was used to assess anxiety symptom severity over the previous two weeks.
“Anxiety symptom severity was assessed using the 7-item Generalized Anxiety Disorder (GAD-7) [35]. The GAD-7 is a self-report measure with seven items. Similar to the PHQ-9, the GAD-7 evaluates anxiety symptoms experienced during the previous two weeks.”
From Using Psychological Artificial Intelligence (Tess) to Relieve Symptoms of Depression and Anxiety: Randomized Controlled Trial (Preprint) (2018) · cites this paper as [35]
Anxiety was measured with the GAD-7, a validated 7-item tool.
“Anxiety was measured using the Generalised Anxiety Disorder assessment (GAD-7), a well validated 7-item tool used to screen and diagnose generalised anxiety disorder in clinical practice and research23”
From Trajectories of anxiety and depressive symptoms during enforced isolation due to COVID-19 in England: a longitudinal observational study (2021) · cites this paper as [23]
Reliable improvement was calculated based on the Patient Health Questionnaire (PHQ-9) and Generalized Anxiety Disorder 7-item scale (GAD-7).
“Reliable improvement was calculated based on 2 severity measures: Patient Health Questionnaire (PHQ-9)21 and Generalized Anxiety Disorder 7-item scale (GAD-7),22 corresponding to depressive and anxiety symptoms respectively, completed by the patient at initial assessment and before every therapy session”
From Quantifying the association between psychotherapy content and clinical outcomes using deep learning (2020) · cites this paper as [22]
Stress refers to more ephemeral perceptions of situational threat, whereas anxiety refers to more generalized and long-lasting feelings of worry and nervousness.
“Whereas stress refers to more ephemeral perceptions of situational threat (Cohen et al., 1983), anxiety as conceptualized by Spitzer et al. (2006) refers to more generalized and long-lasting feelings of worry and nervousness.”
From Media for Coping During COVID-19 Social Distancing: Stress, Anxiety, and Psychological Well-Being (2020) · cites this paper as Spitzer et al., 2006
Both the PHQ-8 and GAD-7 have good internal consistency and demonstrated convergent validity with measures of depression, stress, and anxiety.
“Both the PHQ-8 and GAD-7 have good internal consistency and demonstrated convergent validity with measures of depression, stress, and anxiety.”
From A Therapeutic Relational Agent for Reducing Problematic Substance Use (Woebot): Development and Usability Study (2021) · cites this paper as [43]
Using the threshold score of 10, the GAD-7 has a sensitivity of 89% and a specificity of 82% for GAD; it is considered congruent of DSM-IV as a clinical case for GAD.
“Using the threshold score of 10, the GAD-7 has a sensitivity of 89% and a specificity of 82% for GAD; it is considered congruent of DSM-IV as a clinical case for GAD [67].”
From Low-intensity internet-delivered treatment for generalized anxiety symptoms in routine care: protocol for a randomized controlled trial (2014) · cites this paper as [67]
The GAD-7 is a 7-item self-report questionnaire for generalized anxiety disorder widely used in primary and specialist care as an indicator of anxiety symptoms.
“The GAD-7 is a 7-item self-report questionnaire for generalized anxiety disorder widely used in primary and specialist care as an indicator of anxiety symptoms [36].”
From Evaluating the Effectiveness of an E-Mental Health Intervention for People Living in Lebanon: Protocol for Two Randomized Controlled Trials (2021) · cites this paper as [36]
The GAD-7 may be used to screen for pathological anxiety.
“The 7-item Generalized Anxiety Disorders Scale (GAD-7) may be used to screen for pathological anxiety [73].”
The Generalized Anxiety Disorder-7 (GAD-7) is a 7-item questionnaire that is clinically used for measuring and tracking anxiety severity.
“The Generalized Anxiety Disorder-7 (GAD-7) is a 7-item questionnaire that is clinically used for measuring and tracking anxiety severity [38].”
From Physician Anxiety and Burnout: Symptom Correlates and a Prospective Pilot Study of App-Delivered Mindfulness Training (2020) · cites this paper as [38]
GAD-7 has been shown to have reliability, criterion, construct, factorial, and procedural validity, with cutoff points optimizing sensitivity (89%) and specificity (82%).
“Anxiety was measured on the Generalized Anxiety Disorder (GAD-7) scale, which has been shown to have reliability, criterion, construct, factorial, and procedural validity. Cutoff points that optimized sensitivity (89%) and specificity (82%) were identified.”
The GAD-7 is a valid, brief self-report tool to assess the frequency and severity of anxious thoughts and behaviors over the past 2 weeks.
“The Generalized Anxiety Disorder 7-item scale (GAD-7) [20] is a valid, brief self-report tool to assess the frequency and severity of anxious thoughts and behaviors over the past 2 weeks.”
Anxiety symptoms were assessed using GAD-7.
“Anxiety symptoms were assessed using GAD-7 [43].”
From Chatbot-Delivered Cognitive Behavioral Therapy in Adolescents With Depression and Anxiety During the COVID-19 Pandemic: Feasibility and Acceptability Study (2022) · cites this paper as [43]
Anxiety was assessed with the GAD-7, which has good psychometric properties, including sensitivity and specificity for diagnostic GAD and good reliability (Cronbach's α = 0.89).
“Symptoms of anxiety were assessed using the Generalized Anxiety Disorder-7 (GAD-7), which has demonstrated good psychometric properties, including sensitivity and specificity for diagnostic GAD and a good reliability (Cronbach’s α = 0.89) [23].”
From Anxiety, depression and risk of post-traumatic stress disorder in health workers: the relationship with burnout during COVID-19 pandemic in Italy (2021) · cites this paper as [23]
A GAD-7 score of 10 or greater is typically used to identify a likely diagnosis of generalized anxiety disorder.
“The GAD-7 has demonstrated strong psychometric properties, and a score of 10 or greater is typically used to identify a likely diagnosis of generalized anxiety disorder [36,37].”
From Initial Outcomes of Transdiagnostic Internet-Delivered Cognitive Behavioral Therapy Tailored to Public Safety Personnel: Longitudinal Observational Study (2021) · cites this paper as [37]
Generalized Anxiety Disorder-7 (GAD-7) is a brief measure of general anxiety symptoms.
“Generalized Anxiety Disorder-7 (GAD-7) is a brief measure of general anxiety symptoms [37].”
From Initial Outcomes of Transdiagnostic Internet-Delivered Cognitive Behavioral Therapy Tailored to Public Safety Personnel: Longitudinal Observational Study (2021) · cites this paper as [37]
The GAD-7 has demonstrated strong psychometric properties.
“The GAD-7 has demonstrated strong psychometric properties, and a score of 10 or greater is typically used to identify a likely diagnosis of generalized anxiety disorder [36,37].”
From Initial Outcomes of Transdiagnostic Internet-Delivered Cognitive Behavioral Therapy Tailored to Public Safety Personnel: Longitudinal Observational Study (2021) · cites this paper as [37]
Anxiety was also evaluated with the Generalised Anxiety Disorder-7 (GAD-7) scale and Beck Anxiety Inventory (BAI).
“Anxiety was also evaluated with the Generalised Anxiety Disorder-7 (GAD- 7) scale [54] and Beck Anxiety Inventory (BAI) [55].”
Cites
The PHQ-9: Validity of a brief depression severity measure
Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2001.016009606.x · Cited by 44,910 · see citing works
Self-citation(1992) · PubMed · Cited by 33,716 · see citing works
An inventory for measuring clinical anxiety: Psychometric properties.
Beck, A. T., Epstein, N., Brown, G., & Steer, R. A. (1988) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.56.6.893 · Cited by 14,407 · see citing works
The assessment of anxiety states by rating
HAMILTON, M. (1959) · British Journal of Medical Psychology · doi:10.1111/j.2044-8341.1959.tb00467.x · Cited by 11,455 · see citing works
Spitzer, R. L. (1999) · JAMA · doi:10.1001/jama.282.18.1737 · Cited by 9,802 · see citing works
Self-citationThe validity of the Hospital Anxiety and Depression Scale
Bjelland, I., Dahl, A. A., Haug, T. T., & Neckelmann, D. (2002) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(01)00296-3 · Cited by 9,779 · see citing works
The PHQ-9: A New Depression Diagnostic and Severity Measure
Kroenke, K., & Spitzer, R. L. (2002) · Psychiatric Annals · doi:10.3928/0048-5713-20020901-06 · Cited by 5,898 · see citing works
Self-citationThe MOS Short-form General Health Survey: Reliability and Validity in a Patient Population
Stewart, A. L., Hays, R. D., & Ware, J. E. (1988) · Medical Care · doi:10.1097/00005650-198807000-00007 · Cited by 3,339 · see citing works
Effect Sizes for Interpreting Changes in Health Status
Kazis, L. E., Anderson, J. J., & Meenan, R. F. (1989) · Medical Care · doi:10.1097/00005650-198903001-00015 · Cited by 2,401 · see citing works
Detecting and monitoring depression with a two-item questionnaire (PHQ-2)
Löwe, B., Kroenke, K., & Gräfe, K. (2005) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2004.09.006 · Cited by 1,473 · see citing works
Self-citationDeyo, R. A., Diehr, P. H., & Patrick, D. L. (1991) · Controlled Clinical Trials · doi:10.1016/s0197-2456(05)80019-4 · Cited by 1,369 · see citing works
Monitoring Depression Treatment Outcomes With the Patient Health Questionnaire-9
L??we, B., Un??tzer, J., Callahan, C. M., Perkins, A. J., & Kroenke, K. (2004) · Medical Care · doi:10.1097/00005650-200412000-00006 · Cited by 1,354 · see citing works
Self-citationLOWE, B. (2004) · Journal of Affective Disorders · doi:10.1016/s0165-0327(02)00237-9 · Cited by 1,060 · see citing works
Self-citationDSM-III-R Generalized Anxiety Disorder in the National Comorbidity Survey
Wittchen, H.-U. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950050015002 · Cited by 967 · see citing works
The Hopkins Symptom Checklist (HSCL)
Derogatis, L. R., Lipman, R. S., Rickels, K., UHLENHUTH, E. H., & Covi, L. (2015) · Modern problems of pharmacopsychiatry/Modern trends in pharmacopsychiatry · doi:10.1159/000395070 · Cited by 895 · see citing works
Practitioner’s Guide to Empirically Based Measures of Anxiety
(2001) · AABT Clinical Assessment Series · doi:10.1007/b108176 · Cited by 513 · cited 2× · see citing works
“This study reports the development and validation of a measure for evaluating the presence and severity of GAD in clinical practice, the GAD-7, one of the few GAD measures that is also specifically linked to the DSM-IV (Text Revision) criteria.(19,26) A score of 10 or greater on the GAD-7 represents a reasonable cut p…”
MethodWeslen, D., & Morrison, K. M. (2002) · PsycEXTRA Dataset · doi:10.1037/e323162004-001 · Cited by 509 · see citing works
Mental Disorders and Disability Among Patients in a Primary Care Group Practice
Olfson, M., FIREMAN, B. H., Weissman, M. M., Leon, A. C., Sheehan, D. V., Kathol, R. G., Hoven, C. W., & Farber, L. H. (1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.12.1734 · Cited by 404 · see citing works
Zimmerman, M., & Mattia, J. I. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.8.787 · Cited by 375 · see citing works
Assessing depression in primary care with the PHQ-9: Can it be carried out over the telephone?
Pinto-Meza, A., Serrano-Blanco, A., Peñarrubia, M. T., Blanco, E., & Haro, J. M. (2005) · Journal of General Internal Medicine · doi:10.1111/j.1525-1497.2005.0144.x · Cited by 347 · see citing works
Carter, R., Wittchen, H., Pfister, H., & Kessler, R. (2001) · Depression and Anxiety · doi:10.1002/da.1020 · Cited by 345 · see citing works
The epidemiology of generalized anxiety disorder
Kessler, R. C., Keller, M. B., & Wittchen, H.-U. (2001) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(05)70204-5 · Cited by 337 · see citing works
Löwe, B., Gräfe, K., Zipfel, S., Witte, S., Loerch, B., & Herzog, W. (2004) · Psychotherapy and Psychosomatics · doi:10.1159/000080393 · Cited by 301 · see citing works
Self-citationIdentifying depression in primary care: a literature synthesis of case-finding instruments
Williams, J. W., Pignone, M. P., Ramı́rez, G., & Stellato, C. P. (2002) · General Hospital Psychiatry · doi:10.1016/s0163-8343(02)00195-0 · Cited by 288 · see citing works
Self-citationKlinkman, M. (1997) · General Hospital Psychiatry · doi:10.1016/s0163-8343(96)00145-4 · Cited by 284 · see citing works
Clark, D. A., Steer, R. A., & Beck, A. T. (1994) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.103.4.645 · Cited by 274 · see citing works
Kessler, R. C., Brandenburg, N. A., Lane, M. C., Roy‐Byrne, P., STANG, P. D., Stein, D. J., & Wïttchen, H. (2005) · Psychological Medicine · doi:10.1017/s0033291705004538 · Cited by 237 · see citing works
(2004) · PubMed · Cited by 125 · see citing works
Prevalence of mental disorders in primary care. Implications for screening
Leon, A. C. (1995) · Archives of Family Medicine · doi:10.1001/archfami.4.10.857 · Cited by 115 · see citing works
Fricchione, G. L. (2004) · New England Journal of Medicine · doi:10.1056/nejmcp022342 · Cited by 99 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection
Kroenke, K., Spitzer, R. L., Williams, J. B. W., Monahan, P. O., & Löwe, B. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-5-200703060-00004 · Cited by 4,741 · see citing works
Self-citationLöwe, B., Decker, O., Müller, S., Brähler, E., Schellberg, D., Herzog, W., & Herzberg, P. Y. (2008) · Medical Care · doi:10.1097/mlr.0b013e318160d093 · Cited by 4,527 · see citing works
Self-citationKroenke, K., Spitzer, R. L., Williams, J. B. W., & Löwe, B. (2010) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2010.03.006 · Cited by 4,057 · see citing works
Self-citationAn Ultra-Brief Screening Scale for Anxiety and Depression: The PHQ–4
Kroenke, K., Spitzer, R. L., Williams, J. B. W., & Löwe, B. (2009) · Psychosomatics · doi:10.1016/s0033-3182(09)70864-3 · Cited by 4,261 · see citing works
Self-citationHuang, Y., & Zhao, N. (2020) · Psychiatry Research · doi:10.1016/j.psychres.2020.112954 · Cited by 3,736 · see citing works
Fitzpatrick, K. K., Darcy, A., & Vierhile, M. (2017) · JMIR Mental Health · doi:10.2196/mental.7785 · Cited by 2,730 · see citing works
“The Generalized Anxiety Disorder 7-item scale (GAD-7) [20] is a valid, brief self-report tool to assess the frequency and severity of anxious thoughts and behaviors over the past 2 weeks.”
MethodMental health problems and social media exposure during COVID-19 outbreak
Gao, J., Zheng, P., Jia, Y., Chen, H., Mao, Y., Chen, S., Wang, Y., Fu, H., & Dai, J. (2020) · PLoS ONE · doi:10.1371/journal.pone.0231924 · Cited by 2,830 · see citing works
“Anxiety was assessed by Chinese version of generalized anxiety disorder scale (GAD-7) [15, 16] , which consists 7 symptoms.”
BackgroundMethodLöwe, B., Wahl, I., Rose, M., Spitzer, C., Glaesmer, H., Wingenfeld, K., Schneider, A., & Brähler, E. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.06.019 · Cited by 2,473 · see citing works
Self-citationPlummer, F., Manea, L., Trepel, D., & McMillan, D. (2016) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2015.11.005 · Cited by 1,882 · see citing works
Coronavirus Anxiety Scale: A brief mental health screener for COVID-19 related anxiety
Lee, S. A. (2020) · Death Studies · doi:10.1080/07481187.2020.1748481 · Cited by 1,649 · see citing works
Zhou, S.-J., Zhang, L.-G., Wang, L.-L., Guo, Z.-C., Wang, J.-Q., Chen, J.-C., Liu, M., Chen, X., & Chen, J.-X. (2020) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-020-01541-4 · Cited by 1,464 · see citing works
González-Sanguino, C., Ausín, B., Castellanos, M. Á., Saiz, J., López-Gómez, A., Ugidos, C., & Muñoz, M. (2020) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.05.040 · Cited by 1,373 · see citing works
Elmer, T., Mepham, K., & Stadtfeld, C. (2020) · PLOS ONE · doi:10.1371/journal.pone.0236337 · Cited by 1,421 · see citing works
“Anxiety was measured by the German version of the Generalized Anxiety Disorder-7 scale [25, 26].”
MethodRossi, R., Socci, V., Talevi, D., Mensi, S., Niolu, C., Pacitti, F., Di Marco, A., Rossi, A., Siracusano, A., & Di Lorenzo, G. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00790 · Cited by 1,448 · see citing works
Hampl, S. E., Hassink, S. G., Skinner, A. C., Armstrong, S. C., Barlow, S. E., Bolling, C. F., Avila Edwards, K. C., Eneli, I., Hamre, R., Joseph, M. M., et al. (2023) · Pediatrics · doi:10.1542/peds.2022-060640 · Cited by 1,389 · see citing works
Stress and parenting during the global COVID-19 pandemic
Brown, S. M., Doom, J. R., Lechuga-Peña, S., Watamura, S. E., & Koppels, T. (2020) · Child Abuse & Neglect · doi:10.1016/j.chiabu.2020.104699 · Cited by 1,344 · see citing works
Patricios, J., Schneider, K., Dvořák, J., Ahmed, O. H., Blauwet, C. A., Cantu, R. C., Davis, G. A., Echemendía, R. J., Makdissi, M., McNamee, M., et al. (2023) · British Journal of Sports Medicine · doi:10.1136/bjsports-2023-106898 · Cited by 1,295 · see citing works
Poverty, depression, and anxiety: Causal evidence and mechanisms
Ridley, M., Rao, G., Schilbach, F., & Patel, V. (2020) · Science · doi:10.1126/science.aay0214 · Cited by 1,220 · see citing works
Liu, C. H., Zhang, E., Wong, G. T. F., Hyun, S., & Hahm, H. “. (2020) · Psychiatry Research · doi:10.1016/j.psychres.2020.113172 · Cited by 1,157 · see citing works
Regier, D. A., Narrow, W. E., Clarke, D. E., Kraemer, H. C., Kuramoto, S. J., Kuhl, E. A., & Kupfer, D. J. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12070999 · Cited by 1,163 · see citing works
Mental health status of people isolated due to Middle East Respiratory Syndrome
Jeong, H., Yim, H. W., Song, Y.-J., Ki, M., Min, J.-A., Cho, J., & Chae, J.-H. (2016) · Epidemiology and Health · doi:10.4178/epih.e2016048 · Cited by 1,103 · see citing works
Fancourt, D., Steptoe, A., & Bu, F. (2021) · The Lancet Psychiatry · doi:10.1016/s2215-0366(20)30482-x · Cited by 1,161 · see citing works
Pieh, C., Budimir, S., & Probst, T. (2020) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2020.110186 · Cited by 1,122 · see citing works
Postuma, R. B., Iranzo, Á., Hu, M., Högl, B., Boeve, B. F., Manni, R., Oertel, W. H., Arnulf, I., Ferini‐Strambi, L., Puligheddu, M., et al. (2019) · Brain · doi:10.1093/brain/awz030 · Cited by 1,173 · see citing works
O'Connor, R. C., Wetherall, K., Cleare, S., McClelland, H., Melson, A. J., Niedzwiedz, C. L., O'Carroll, R. E., O'Connor, D. B., Platt, S., Scowcroft, E., et al. (2021) · The British Journal of Psychiatry · doi:10.1192/bjp.2020.212 · Cited by 1,042 · see citing works
Runowicz, C. D., Leach, C. R., Henry, N. L., Henry, K. S., Mackey, H. T., Cowens-Alvarado, R. L., Cannady, R. S., Pratt-Chapman, M. L., Edge, S. B., Jacobs, L. A., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.64.3809 · Cited by 1,071 · see citing works
Rossi, R., Socci, V., Pacitti, F., Di Lorenzo, G., Di Marco, A., Siracusano, A., & Rossi, A. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.10185 · Cited by 1,086 · see citing works
Mental Health Smartphone Apps: Review and Evidence-Based Recommendations for Future Developments
Bakker, D., Kazantzis, N., Rickwood, D., & Rickard, N. (2016) · JMIR Mental Health · doi:10.2196/mental.4984 · Cited by 886 · see citing works
The Global Prevalence of Anxiety Among Medical Students: A Meta-Analysis
Tian-Ci Quek, T., Wai-San Tam, W., X. Tran, B., Zhang, M., Zhang, Z., Su-Hui Ho, C., & Chun-Man Ho, R. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16152735 · Cited by 990 · see citing works
“As a comparison, the prevalence of anxiety among the general population was found to be 3% as screened by the DASS-21 [96], 8.2% as screened by the GAD-7 [97], not more than 10% as screened by the BAI-21 [98] and not more than 25% as screened by the HADS-A [99].”
MethodInfluentialNetwork analysis of depression and anxiety symptom relationships in a psychiatric sample
Beard, C., Millner, A. J., Forgeard, M. J. C., Fried, E. I., Hsu, K. J., Treadway, M. T., Leonard, C. V., Kertz, S. J., & Björgvinsson, T. (2016) · Psychological Medicine · doi:10.1017/s0033291716002300 · Cited by 929 · see citing works
Thomas, J. L., Wilk, J. E., Riviere, L. A., McGurk, D., Castro, C. A., & Hoge, C. W. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.54 · Cited by 935 · see citing works
Popova, V., Daly, E. J., Trivedi, M., Cooper, K., Lane, R., Lim, P., Mazzucco, C., Hough, D., Thase, M. E., Shelton, R. C., et al. (2019) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2019.19020172 · Cited by 904 · see citing works
Depression and Anxiety in Hong Kong during COVID-19
Choi, E. P. H., Hui, B. P. H., & Wan, E. Y. F. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17103740 · Cited by 905 · see citing works
Lipson, S. K., Zhou, S., Abelson, S., Heinze, J., Jirsa, M., Morigney, J., Patterson, A., Singh, M., & Eisenberg, D. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.03.038 · Cited by 877 · see citing works
Claxton, K., Martin, S., Soares, M. O., Rice, N., Spackman, E., Hinde, S., Devlin, N. J., Smith, P., & Sculpher, M. J. (2015) · Health Technology Assessment · doi:10.3310/hta19140 · Cited by 859 · see citing works
Staab, J. P., Eckhardt-Henn, A., Horii, A., Jacob, R., Strupp, M., Brandt, T., & Bronstein, A. (2017) · Journal of Vestibular Research · doi:10.3233/ves-170622 · Cited by 840 · see citing works
Islam, M. A., Barna, S. D., Raihan, H., Khan, M. N. A., & Hossain, M. T. (2020) · PLOS ONE · doi:10.1371/journal.pone.0238162 · Cited by 834 · see citing works
Torous, J., Kiang, M. V., Lorme, J., & Onnela, J.-P. (2016) · JMIR Mental Health · doi:10.2196/mental.5165 · Cited by 758 · see citing works
“…Mini-International Neuropsychiatric Interview (MINI) [55], Patient Health Questionnaire 8 (PHQ-8) [56], General Anxiety Disorder Questionnaire 7 (GAD-7) [57], Pittsburgh Sleep Quality Index (PSQI) [58], and the Warning Signals Scale (WSS), which assess for risk of relapse in schizophrenia [59].”
BackgroundDistinguishing features of long COVID identified through immune profiling
Klein, J., Wood, J., Jaycox, J. R., Dhodapkar, R. M., Lu, P., Gehlhausen, J. R., Tabachnikova, A., Greene, K., TABACOF, L. R., Malik, A. A., et al. (2023) · Nature · doi:10.1038/s41586-023-06651-y · Cited by 821 · see citing works
The prevalence of depression, anxiety, and sleep disturbances in COVID-19 patients: a meta-analysis
Deng, J., Zhou, F., Hou, W., Silver, Z., Wong, C. Y., Chang, O., Huang, E., & Zuo, Q. K. (2021) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14506 · Cited by 771 · see citing works
Meltzer-Brody, S., Colquhoun, H., Riesenberg, R., Epperson, C. N., Deligiannidis, K. M., Rubinow, D. R., Li, H., Sankoh, A. J., Clemson, C., Schacterle, A., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31551-4 · Cited by 795 · see citing works
Anxiety and coping strategies among nursing students during the covid-19 pandemic
Savitsky, B., Findling, Y., Ereli, A., & Hendel, T. (2020) · Nurse Education in Practice · doi:10.1016/j.nepr.2020.102809 · Cited by 812 · see citing works
Runowicz, C. D., Leach, C. R., Henry, N. L., Henry, K. S., Mackey, H. T., Cowens‐Alvarado, R. L., Cannady, R. S., Pratt‐Chapman, M. L., Edge, S. B., Jacobs, L. A., et al. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21319 · Cited by 728 · see citing works
Alsoufi, A., Alsuyihili, A., Msherghi, A. A. A., Elhadi, A., Atiyah, H., Ashini, A., Ashwieb, A., Ghula, M., Hasan, H. B., Abudabuos, S., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0242905 · Cited by 749 · see citing works
Andersen, B. L., DeRubeis, R. J., Berman, B. S., Gruman, J., Champion, V. L., Massie, M. J., Holland, J. C., Partridge, A. H., Bak, K., Somerfield, M. R., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.52.4611 · Cited by 735 · see citing works
Groarke, J. M., Berry, E., Graham-Wisener, L., McKenna-Plumley, P. E., McGlinchey, E., & Armour, C. (2020) · PLOS ONE · doi:10.1371/journal.pone.0239698 · Cited by 727 · see citing works
The Somatic Symptom Scale–8 (SSS-8): A Brief Measure of Somatic Symptom Burden
Gierk, B., Kohlmann, S., Kroenke, K., Spangenberg, L., Zenger, M., Brähler, E., & Löwe, B. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.12179 · Cited by 740 · see citing works
Self-citationShevlin, M., McBride, O., Murphy, J., Miller, J. G., Hartman, T. K., Levita, L., Mason, L., Martinez, A. P., McKay, R., Stocks, T. V. A., et al. (2020) · BJPsych Open · doi:10.1192/bjo.2020.109 · Cited by 770 · see citing works
Casagrande, M., Favieri, F., Tambelli, R., & Forte, G. (2020) · Sleep Medicine · doi:10.1016/j.sleep.2020.05.011 · Cited by 735 · see citing works
Daly, E. J., Singh, J. B., Fedgchin, M., Cooper, K., Lim, P., Shelton, R. C., Thase, M. E., Winokur, A., Van Nueten, L., Manji, H., et al. (2018) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2017.3739 · Cited by 718 · see citing works
Mountjoy, M., Ackerman, K. E., Bailey, D. M., Burke, L. M., Constantini, N., Hackney, A. C., Heikura, I. A., Melin, A., Pensgaard, A. M., Stellingwerff, T., et al. (2023) · British Journal of Sports Medicine · doi:10.1136/bjsports-2023-106994 · Cited by 724 · see citing works
Depression, anxiety and somatization in primary care: Syndrome overlap and functional impairment
Löwe, B., Spitzer, R. L., Williams, J. B. W., Mussell, M., Schellberg, D., & Kroenke, K. (2008) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2008.01.001 · Cited by 706 · see citing works
Self-citationFulmer, R., Joerin, A., Gentile, B., Lakerink, L., & Rauws, M. (2018) · doi:10.2196/preprints.9782 · Cited by 715 · see citing works
Russell, B. S., Hutchison, M., Tambling, R. R., Tomkunas, A. J., & Horton, A. L. (2020) · Child Psychiatry & Human Development · doi:10.1007/s10578-020-01037-x · Cited by 715 · see citing works
Johnson, S. U., Ulvenes, P. G., Øktedalen, T., & Hoffart, A. (2019) · Frontiers in Psychology · doi:10.3389/fpsyg.2019.01713 · Cited by 673 · see citing works
Clark, D. M. (2011) · International Review of Psychiatry · doi:10.3109/09540261.2011.606803 · Cited by 699 · see citing works
Holt, R. I. G., DeVries, J. H., Hess-Fischl, A., Hirsch, I. B., Kirkman, M. S., Klupa, T., Ludwig, B., Nørgaard, K., Pettus, J., Renard, E., et al. (2021) · Diabetes Care · doi:10.2337/dci21-0043 · Cited by 699 · see citing works
Harnessing context sensing to develop a mobile intervention for depression
Burns, M. N., Begale, M., Duffecy, J., Gergle, D., Karr, C. J., Giangrande, E., & Mohr, D. C. (2011) · Journal of Medical Internet Research · doi:10.2196/jmir.1838 · Cited by 646 · see citing works
The Religious and Spiritual Struggles Scale: Development and initial validation.
Exline, J. J., Pargament, K. I., Grubbs, J. B., & Yali, A. M. (2014) · Psychology of Religion and Spirituality · doi:10.1037/a0036465 · Cited by 682 · see citing works
Garcia-Campayo, J., Zamorano, E., Ruiz, M. A., Pardo, A., Perez-Paramo, M., Lopez-Gomez, V., Freire, O., & Rejas, J. (2010) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-8-8 · Cited by 673 · see citing works
Freeman, D., Sheaves, B., Goodwin, G. M., Yu, L.-M., Nickless, A., Harrison, P. J., Emsley, R., Luik, A. I., Foster, R. G., Wadekar, V., et al. (2017) · The Lancet Psychiatry · doi:10.1016/s2215-0366(17)30328-0 · Cited by 652 · see citing works
The impact of minority stress on mental health and substance use among sexual minority women.
Lehavot, K., & Simoni, J. M. (2011) · Journal of Consulting and Clinical Psychology · doi:10.1037/a0022839 · Cited by 652 · see citing works
Jennings, P. A., Brown, J. L., Frank, J. L., Doyle, S., Oh, Y., Davis, R., Rasheed, D., DeWeese, A., DeMauro, A. A., Cham, H., et al. (2017) · Journal of Educational Psychology · doi:10.1037/edu0000187 · Cited by 645 · see citing works
Barzilay, R., Moore, T. M., Greenberg, D. M., DiDomenico, G. E., Brown, L. A., White, L. K., Gur, R. C., & Gur, R. E. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-00982-4 · Cited by 634 · see citing works
Toussaint, A., Hüsing, P., Gumz, A., Wingenfeld, K., Härter, M., Schramm, E., & Löwe, B. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.01.032 · Cited by 641 · see citing works
Self-citationBlumenfeld, A., Varon, S., Wilcox, T., Buse, D., Kawata, A., Manack, A., Goadsby, P., & Lipton, R. (2011) · Cephalalgia · doi:10.1177/0333102410381145 · Cited by 627 · see citing works
Marroquín, B., Vine, V., & Morgan, R. M. (2020) · Psychiatry Research · doi:10.1016/j.psychres.2020.113419 · Cited by 554 · see citing works
Solomou, I., & Constantinidou, F. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17144924 · Cited by 591 · see citing works
“Both questionnaires were designed for self-administration and have been validated in the general population [19,20].”
MethodBenke, C., Autenrieth, L. K., Asselmann, E., & Pané-Farré, C. A. (2020) · Psychiatry Research · doi:10.1016/j.psychres.2020.113462 · Cited by 585 · see citing works
Mental health outcomes in transgender and nonbinary youths receiving gender-affirming care
Tordoff, D. M., Wanta, J. W., Collin, A., Stepney, C., Inwards-Breland, D. J., & Ahrens, K. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.0978 · Cited by 692 · see citing works
Huang, L., Li, X., Gu, X., Zhang, H., Ren, X., Guo, L., Liu, M., Wang, Y., Cui, D., Wang, Y., et al. (2022) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(22)00126-6 · Cited by 613 · see citing works
Improving access to psychological therapy: initial evaluation of two UK demonstration sites
Clark, D. M., Layard, R., Smithies, R., Richards, D. A., Suckling, R., & Wright, B. (2009) · Behaviour Research and Therapy · doi:10.1016/j.brat.2009.07.010 · Cited by 599 · see citing works
Bäuerle, A., Teufel, M., Musche, V., Weismüller, B., Kohler, H., Hetkamp, M., Dörrie, N., Schweda, A., & Skoda, E.-M. (2020) · Journal of Public Health · doi:10.1093/pubmed/fdaa106 · Cited by 597 · see citing works
Depression and anxiety in heart failure: a review.
Celano, C. M., Villegas, A. C., Albanese, A. M., Gaggin, H. K., & Huffman, J. C. (2018) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000162 · Cited by 610 · see citing works
Fedgchin, M., Trivedi, M., Daly, E. J., Melkote, R., Lane, R., Lim, P., Vitagliano, D., Blier, P., Fava, M., Liebowitz, M., et al. (2019) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyz039 · Cited by 606 · see citing works
Raman, B., Cassar, M. P., Tunnicliffe, E. M., Filippini, N., Griffanti, L., Alfaro‐Almagro, F., Okell, T. W., Sheerin, F., Xie, C., Mahmod, M., et al. (2021) · EClinicalMedicine · doi:10.1016/j.eclinm.2020.100683 · Cited by 605 · see citing works
Richards, D. A., Ekers, D., McMillan, D., Taylor, R. S., Byford, S., Warren, F. C., Barrett, B., Farrand, P. A., Gilbody, S., Kuyken, W., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31140-0 · Cited by 595 · see citing works
Fear of COVID-19 and the mental health consequences in America.
Fitzpatrick, K. M., Harris, C. T., & Drawve, G. R. (2020) · Psychological Trauma Theory Research Practice and Policy · doi:10.1037/tra0000924 · Cited by 598 · see citing works
The role of perceived social support on depression and sleep during the COVID-19 pandemic
Grey, I., Arora, T., Thomas, J., Saneh, A., Tohme, P., & Abi-Habib, R. (2020) · Psychiatry Research · doi:10.1016/j.psychres.2020.113452 · Cited by 587 · see citing works
Bair, M. J., Wu, J., Damush, T. M., Sutherland, J. M., & Kroenke, K. (2008) · Psychosomatic Medicine · doi:10.1097/psy.0b013e318185c510 · Cited by 572 · see citing works
Self-citationCauberghe, V., Van Wesenbeeck, I., De Jans, S., Hudders, L., & Ponnet, K. (2021) · Cyberpsychology, Behavior, and Social Networking · doi:10.1089/cyber.2020.0478 · Cited by 564 · see citing works
Duffy, M. E., Twenge, J. M., & Joiner, T. E. (2019) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2019.04.033 · Cited by 579 · see citing works
Mental Disorder Symptoms among Public Safety Personnel in Canada
Carleton, R. N., Afifi, T. O., Turner, S., Taillieu, T., Duranceau, S., LeBouthillier, D. M., Sareen, J., Ricciardelli, R., MacPhee, R. S., Groll, D., et al. (2018) · The Canadian Journal of Psychiatry · doi:10.1177/0706743717723825 · Cited by 558 · see citing works
Anxiety and depression in the Republic of Ireland during the COVID‐19 pandemic
Hyland, P., Shevlin, M., McBride, O., Murphy, J., Karatzias, T., Bentall, R. P., Martinez, A., & Vallières, F. (2020) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13219 · Cited by 582 · see citing works
Que, J., Shi, L., Deng, J., Liu, J., Zhang, L., Wu, S., Gong, Y., Huang, W., Yuan, K., Yan, W., et al. (2020) · General Psychiatry · doi:10.1136/gpsych-2020-100259 · Cited by 568 · see citing works
Newby, J. M., McKinnon, A., Kuyken, W., Gilbody, S., & Dalgleish, T. (2015) · Clinical Psychology Review · doi:10.1016/j.cpr.2015.06.002 · Cited by 545 · see citing works
Wilson, J. M., Lee, J., Fitzgerald, H. N., Oosterhoff, B. J., Sevi, B., & Shook, N. J. (2020) · Journal of Occupational and Environmental Medicine · doi:10.1097/jom.0000000000001962 · Cited by 563 · see citing works
Validation of the Generalized Anxiety Disorder-7 (GAD-7) among Chinese people with epilepsy
Tong, X., An, D., McGonigal, A., Park, S.-P., & Zhou, D. (2016) · Epilepsy Research · doi:10.1016/j.eplepsyres.2015.11.019 · Cited by 525 · see citing works
Social Media and Mental Health
Braghieri, L., Levy, R., & Makarin, A. (2022) · American Economic Review · doi:10.1257/aer.20211218 · Cited by 617 · see citing works
Palgi, Y., Shrira, A., Ring, L., Bodner, E., Avidor, S., Bergman, Y., Cohen-Fridel, S., Keisari, S., & Hoffman, Y. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.06.036 · Cited by 547 · see citing works
The Sleep Condition Indicator: a clinical screening tool to evaluate insomnia disorder
Espie, C. A., Kyle, S. D., Hames, P., Gardani, M., Fleming, L., & Cape, J. (2014) · BMJ Open · doi:10.1136/bmjopen-2013-004183 · Cited by 517 · see citing works
Rettie, H., & Daniels, J. (2021) · American Psychologist · doi:10.1037/amp0000710 · Cited by 526 · see citing works
Szuhany, K. L., & Simon, N. M. (2022) · JAMA · doi:10.1001/jama.2022.22744 · Cited by 541 · see citing works
Craske, M. G., Stein, M. B., Eley, T. C., Milad, M. R., Holmes, A., Rapee, R. M., & Wittchen, H.-U. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.24 · Cited by 652 · see citing works
Report of the NIH Task Force on research standards for chronic low back pain.
Deyo, R. A., Dworkin, S. F., Amtmann, D., Andersson, G., Borenstein, D., Carragee, E., Carrino, J., Chou, R., Cook, K., DeLitto, A., et al. (2014) · The Journal of Pain · doi:10.1016/j.jpain.2014.03.005 · Cited by 533 · see citing works
Alrabiaah, A. A., Temsah, M.-H. A., Al-Eyadhy, A. A., Hasan, G., Alzamil, F. A., Alsubaie, S., Alsohime, F., Jamal, A. A., Alhaboob, A. A. N., Alsaadi, B. M., et al. (2020) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2020.01.005 · Cited by 531 · see citing works
Kroenke, K., Wu, J., Yu, Z., Bair, M. J., Kean, J., Stump, T., & Monahan, P. O. (2016) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000322 · Cited by 504 · see citing works
Self-citationMental health before and during the COVID-19 pandemic in two longitudinal UK population cohorts
Kwong, A. S. F., Pearson, R. M., Adams, M. J., Northstone, K., Tilling, K. M., Major‐Smith, D., Fawns‐Ritchie, C., Bould, H., Warne, N., Zammit, S., et al. (2020) · The British Journal of Psychiatry · doi:10.1192/bjp.2020.242 · Cited by 518 · see citing works
van Spijker, B. A. J., Batterham, P. J., Calear, A. L., Farrer, L., Christensen, H., Reynolds, J., & Kerkhof, A. J. F. M. (2014) · Suicide and Life-Threatening Behavior · doi:10.1111/sltb.12084 · Cited by 492 · see citing works
Fruehwirth, J. C., Biswas, S., & Perreira, K. M. (2021) · PLoS ONE · doi:10.1371/journal.pone.0247999 · Cited by 550 · see citing works
- Authors
- Spitzer, R. L., Kroenke, K., Williams, J. B. W., & Löwe, B.
- Affiliations
- New York State Psychiatric Institute (US)
- Regenstrief Institute (US)
- Heidelberg University (DE)
- Venue
- Archives of Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 2006-05-22
- Volume
- 166
- Issue
- 10
- Pages
- 1092
- ISSN
- 0003-9926 (ISSN-L)
- OpenAlex
- W2043705607
- Cited by
- 31,765
- References
- 30
- Citations by year
- 2026: 4302 · 2025: 4644 · 2024: 4110 · 2023: 3925 · 2022: 3781 · 2021: 3462 · 2020: 2253 · 2019: 1260 · 2018: 997 · 2017: 806 · 2016: 577 · 2015: 515 · 2014: 412 · 2013: 254 · 2012: 192
- FWCI
- 37.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Archives of Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Social Sciences › Psychology › Social Psychology › Mental Health Treatment and Access
- Social Sciences › Decision Sciences › Management Science and Operations Research › Psychometric Methodologies and Testing
- Keywords
- generalized anxiety disorder, GAD-7, screening, diagnostic validity, reliability statistics, functional disability, disability days, health care utilization, comorbid depression, primary care, anxiety levels
- MeSH terms
- Adult, Anxiety Disorders, Female, Humans, Male, Mental Status Schedule, Middle Aged, Surveys and Questionnaires, Retrospective Studies, United States, Reproducibility of Results, Incidence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review